7:30 AM
 | 
Sep 13, 2018
 |  BC Extra  |  Financial News

Xenon further strengthens balance sheet with $63M follow-on

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) raised $63 million through the sale of 4.5 million shares at $14 in a follow-on underwritten by Jefferies and Stifel.

The price is a 2% discount to Xenon's closing price of $14.25 on Wednesday, when it proposed the offering after market hours. Xenon was down $0.30 to...

Read the full 231 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >